Mode
Text Size
Log in / Sign up

Kidney transplant recipients

Part of Kidney Diseases

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for kidney transplant recipients

5 trials tracked for kidney transplant recipients: 2 in phase 3 or 4 and 1 with published results. The most-cited published study has 31 citations.

5Trials tracked
2Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 2 Phase 2 3
  1. Phase 4 Envarsus XR Compared to Immediate Release Tacrolimus Completed · 31 cited
  2. Phase 4 Evaluate Effects and Safety of Pre-load Myfortic® in Transplant Patients Completed
  3. Phase 2 Treg Modulation With CD28 and IL-6 Receptor Antagonists Completed
  4. Phase 2 COVID-19 Protection After Transplant Pilot Study Completed
  5. Phase 2 COVID Protection After Transplant-Immunosuppression Reduction Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Kidney Diseases

Related studies from across the Kidney Diseases family.

cGAS-STING signaling pathway activation drives inflammation, fibrosis, and functional decline in various kidney diseases
Neurology Sys. Review
cGAS-STING signaling pathway activation drives inflammation, fibrosis, and functional decline in various kidney diseases Immune pathway linked to kidney disease progression
This systematic review explores the role of the cGAS-STING signaling pathway in renal pathologies. The authors conclude that this pathway is…
A newly mapped immune pathway may drive kidney damage, opening doors for future treatments.
Post-translational modifications represent a critical target for precise molecular intervention in diabetic kidney disease
Diabetes & Endocrinology Sys. Review
Post-translational modifications represent a critical target for precise molecular intervention in diabetic kidney disease Protein modifications may drive diabetic kidney disease progression
This systematic review examines the role of post-translational modifications (PTMs) such as phosphorylation and acetylation in diabetic kidn…
A new review reveals how tiny protein changes fuel diabetic kidney disease, opening doors for targeted treatments.
Machine learning models show high diagnostic accuracy for predicting pediatric cardiac surgery associated acute kidney injury
Cardiology Meta-analysis
Machine learning models show high diagnostic accuracy for predicting pediatric cardiac surgery associated acute kidney injury Machine Learning Models Show Promise Predicting Pediatric Kidney Injury
This meta-analysis of 7 studies evaluated the diagnostic accuracy of machine learning models for predicting pediatric cardiac surgery associ…
New analysis shows machine learning models can accurately predict kidney injury in children undergoing cardiac surgery, though more testing …
Continuous renal replacement therapy may support metabolic and circulatory stability in preterm infants with AKI
Rheumatology Sys. Review
Continuous renal replacement therapy may support metabolic and circulatory stability in preterm infants with AKI CRRT Treatment Shows Promise for Infants with Kidney Injury
This case report and literature review describes the use of continuous renal replacement therapy (CRRT) for a very low birth weight preterm …
A new case report highlights how continuous renal replacement therapy may help stabilize very low birth weight infants facing acute kidney i…
Programmed cell death pathways form a spatiotemporally regulated network driving tubular damage in renal IRI
Allergy & Immunology Sys. Review
Programmed cell death pathways form a spatiotemporally regulated network driving tubular damage in renal IRI New research identifies key pathways driving acute kidney injury
This systematic review examines the roles of pyroptosis, ferroptosis, cuproptosis, and necroptosis as key mediators of inflammation and oxid…
Researchers have mapped out a complex network of cell death pathways that drive inflammation and damage in patients with acute kidney injury…
Active stone-directed intervention reduces odds of composite recurrence and surgery for asymptomatic kidney stones
Urology Meta-analysis
Active stone-directed intervention reduces odds of composite recurrence and surgery for asymptomatic kidney stones Active Intervention Reduces Surgery for Patients with Kidney Stones
This meta-analysis of 592 patients found that active stone-directed intervention significantly reduced the odds of composite recurrence (OR …
Active treatment for asymptomatic kidney stones may lower the risk of future surgeries and stone growth while maintaining a similar safety p…
Ambulatory hypertension in pediatric chronic kidney disease patients increases risk of left ventricular hypertrophy
Pediatrics Meta-analysis
Ambulatory hypertension in pediatric chronic kidney disease patients increases risk of left ventricular hypertrophy High Blood Pressure Linked to Heart Changes in Children
This meta-analysis of 51 studies involving 6509 children with chronic kidney disease found that ambulatory hypertension is associated with i…
New data shows a strong link between high blood pressure and heart muscle thickening in children with chronic kidney disease.
Roxadustat increases odds of vascular access thrombosis and all-cause mortality in patients with chronic kidney disease
Drug Pipeline Meta-analysis
Roxadustat increases odds of vascular access thrombosis and all-cause mortality in patients with chronic kidney disease Roxadustat Linked to Higher Risk of Blood Clots in Kidney Patients
This systematic review and meta-analysis of 11,418 adults with chronic kidney disease found that roxadustat is associated with higher odds o…
A review of over 11,000 patients suggests roxadustat may increase the risk of blood clots and death for those with chronic kidney disease.
Cystatin C shows good diagnostic performance with an AUC of 0.88 for early detection of SA-AKI
Nephrology Meta-analysis
Cystatin C shows good diagnostic performance with an AUC of 0.88 for early detection of SA-AKI Cystatin C shows promise for early detection of kidney injury
This meta-analysis of 17 studies evaluates the diagnostic performance of Cystatin C for detecting acute kidney injury in patients with sepsi…
A new look at 17 studies suggests that Cystatin C could help doctors identify kidney damage in sepsis patients much earlier than current met…
Semaglutide reduces risk of kidney decline or death in type 2 diabetes and CKD
Diabetes & Endocrinology RCT
Semaglutide reduces risk of kidney decline or death in type 2 diabetes and CKD Semaglutide lowers kidney and heart risks in type 2 diabetes patients
This randomized controlled trial enrolled 3,533 participants with type 2 diabetes and chronic kidney disease. Once-weekly subcutaneous semag…
A large trial shows once-weekly semaglutide reduces kidney failure and death risks in people with type 2 diabetes and chronic kidney disease…
Gut microbiota dysbiosis and microbial metabolites impair renal function in sepsis-associated acute kidney injury
Nephrology Sys. Review
Gut microbiota dysbiosis and microbial metabolites impair renal function in sepsis-associated acute kidney injury Sepsis may damage kidneys by letting gut bacteria toxins leak into the blood
This narrative review examines the role of gut microbiota dysbiosis in sepsis-associated acute kidney injury and acute kidney injury. The au…
A review suggests that sepsis changes gut bacteria, causing harmful toxins to leak and hurt kidneys in humans and animals.
Jinlida Granule reduces serum creatinine and HbA1c in diabetic kidney disease patients across a meta-analysis
Drug Pipeline Meta-analysis
Jinlida Granule reduces serum creatinine and HbA1c in diabetic kidney disease patients across a meta-analysis Jinlida Granule lowers key kidney markers in diabetic kidney disease patients
This systematic review and meta-analysis evaluated Jinlida Granule for diabetic kidney disease in 1,341 patients. The pooled analysis showed…
A large review of 1,341 patients found Jinlida Granule significantly lowered kidney stress markers and blood sugar levels compared to standa…